Advertisement

Forum

Update
  • 13 Downloads

Keywords

Initial Public Offering Parallel Trade International Clinical Trial Registry Platform Electronic Patient Record System Secure Supply Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

Reference

  1. Laine C, Horton R, DeAngelis CD, et al. Clinical trial registration: looking back and moving ahead [online]. Available from URL: http://www.icmje.org/clin_trial07.pdf [Accessed 2007 Jul 5]Google Scholar

Reference

  1. Tufts Center for the Study of Drug Development. Results mixed on postmarketing studies of new drugs, according to the Tufts Center for the Study of Drug Development. Media Release: 2007 May 16Google Scholar
  2. Kazi D. Rosiglitazone and implications for pharmacovigilance: postsurveillance data should be systematically collected and publicly available. BMJ 2007 Jun 16; 334 (7606): 1233–4PubMedCrossRefGoogle Scholar

Reference

  1. Firms need to collaborate more to streamline drug development, says EMEA. Scrip 2007 May 4; 3 (3256): 3Google Scholar

Reference

  1. UKCRC R&D Advisory Group to Connecting for Health. Report of research simulations [online]. Available from URL: http://www.ukcrc.org/pdf/CfH%20report%20June%2007%20full.pdf
  2. Butcher J. UK will lose clinical trials if electronic records system is delayed, ABPI warns. BMJ 2007 Jun 2; 334: 1132PubMedCrossRefGoogle Scholar

Reference

  1. Pharma Marketletter. Asia to become a “powerhouse” of global pharmaceutical industry. 21 May 2007 [online]. Available from URL: http://news.marketletter.com/article.php?article=16765533 Google Scholar

Reference

  1. Reuters Health News. Drug companies to pilot two-dimensional bar codes in attempt to reduce counterfeit trade [online]. 4th June 2007. Available from http://www.nelm.nhs.uk?Record%20Viewing/veiwRecord.aspx?id=581381 Google Scholar

Reference

  1. Javitt GH, Hudson K. The right prescription for personalized genetic medicine. Personalized Med 2007 May; 4 (2): 115–8CrossRefGoogle Scholar

Reference

  1. * Sales growth presented in constant dollars, pharmaceutical sales figures measured in $US.Google Scholar
  2. IMS Health. IMS Health reports global pharmaceutical market grew 7.0 percent in 2006, to $643 billion [online]. Media Release: 2007 Mar 20. Available from: URL: http://www.imshealth.com Google Scholar

Reference

  1. Reinhardt UE. Faith based health policy: the urge to privatise. BMJ 2007 Jun 9; 334 (7605): 1193PubMedCrossRefGoogle Scholar

Reference

  1. Procter & Gamble. New study suggests number of pills not a factor when it comes to daily adherence to medication. Media Release: 5 Jun 2007 [online]. Available from URL: http://www.pginvestor.com/phoenix.zhtml?c=104574&p=irol-newsArticle&ID=1011290&highlight= Google Scholar

Reference

  1. Milliman Inc. Milliman Says 2007 Medical cost for ‘American family of four’ is $14,500. Media Release: 15 May 2007 [online]. Available from URL: http://www.milliman.com/news-events/press/pdfs/mmi-2007-PR05-15-07.pdf Google Scholar

Reference

  1. Sustainable Trials Study Group. Towards sustainable clinical trials. BMJ 2007 Mar 31; 334 (7595): 671–3CrossRefGoogle Scholar

Reference

  1. Jena AB, Philipson T. Cost-effectiveness as a price control: the benefit of more-innovative drugs for future patients comes at a (high) cost to today’s patients. Health Affairs 2007 May–Jun; 26 (3): 696–703PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Personalised recommendations